Crohn's Disease Market
You also want an ePaper? Increase the reach of your titles
YUMPU automatically turns print PDFs into web optimized ePapers that Google loves.
smoking habits, progressive healthcare infrastructure and<br />
innovative healthcare solutions.<br />
Europe follows North America in terms of share of the global<br />
Crohn’s disease market. The Crohn’s disease market in Asia<br />
Pacific is projected to expand at a high growth rate. This rise is<br />
primarily due to changing food habits, industrialization, and<br />
innovative diagnostic and treatment options for the disease.<br />
Major players in the market find countries in Asia to be<br />
productive markets for Crohn’s disease with the increasing<br />
incidence of the disease in the countries in the region. They are<br />
making significant investments, which in turn is likely to fuel<br />
the expansion of the market in the region.<br />
Key players operating in the global Crohn’s disease market<br />
include AbbVie Inc., Allergan, Inc., Bayer AG, Bristol-Myers<br />
Squibb, Boehringer Ingelheim GmbH, F. Hoffmann-La Roche,<br />
Eli Lilly and Co., GlaxoSmithKline plc, Janssen Biotech, Inc.,<br />
Johnson & Johnson, Novartis International AG, Pfizer Inc.,<br />
Sanofi, and Takeda Pharmaceutical Company Limited.
Change language